Up 124% in a year, ASX 300 healthcare share lifts off on $35 million acquisition

ASX investors are bidding up the healthcare share amid ongoing growth.

| More on:
healthcare worker overseeing group of aged care residents at table

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

sdf

S&P/ASX 300 Index (ASX: XKO) healthcare share Regis Healthcare Ltd (ASX: REG) is marching higher today.

Shares in the residential aged care provider closed yesterday trading for $5.83. In morning trade on Friday, shares are trading for $5.97 apiece, up 2.4%.

For some context, the ASX 300 is up 0.5% at this same time.

Created with Highcharts 11.4.3Regis Healthcare PriceZoom1M3M6MYTD1Y5Y10YALL1 Sep 202315 Jun 2025Zoom ▾Oct '23Jan '24Apr '24Jul '24Oct '24Jan '25Apr '25Jan '24Jan '24Jul '24Jul '24Jan '25Jan '25www.fool.com.au

As you can see on the chart above, the Regis Healthcare share price is now up 123.6% over the past 12 months. And that doesn't even factor in the two partly franked dividends the company paid out over the year.

Here's what's moving the ASX 300 healthcare stock today.

ASX 300 healthcare stock expands residential aged care footprint

The Regis Healthcare share price is on the rise after the company announced it has entered into binding agreements to acquire two residential aged care homes from Ti Tree Operations.

The ASX 300 healthcare share will pay a net consideration of $35.5 million to the privately-owned residential aged care provider for the new assets.

The residential aged care homes are located in Capel Sound and Mornington in Victoria. They provide a combined 262 beds under the Village Glen trading name.

According to the release, both fully accredited homes had an average occupancy of 96% in Q4 FY 2024.

Commenting on the expansion that looks to be boosting the ASX 300 healthcare share today, Regis CEO Linda Mellors said, "We are excited to add these quality homes to our portfolio and broaden our footprint in Melbourne."

Mellors continued, "We look forward to welcoming the residents, families, employees and communities to Regis and ensuring a seamless transition of services."

Village Glen managing director Chas Jacobsen added:

We are delighted that Regis will be the new owner and custodian of the Capel Sound and Mornington facilities. We look forward to an ongoing and productive relationship between the parties into the future via our co-located retirement village.

The transaction remains subject to the customary regulatory approvals and conditions.

Regis expects the acquisition to settle on 2 December this year. It will be funded by the company's existing cash.

Once the acquisition is complete, and post the September closure of its Weston home in Western Australia, the ASX 300 healthcare share's aged care portfolio will expand to 68 homes with approximately 7,660 beds.

Atop that, Regis' new 112-bed residential aged care home in Camberwell, Victoria is scheduled to open by late 2024.

Regis comments on healthcare reforms

Separately, the ASX 300 healthcare share also applauded the government's bipartisan historic funding reforms to improve Australia's aged care system.

Commenting on those reforms, Mellors said:

After many years of chronic underfunding with a significant portion of the sector operating at a loss, we are now expecting more predictable and sustainable funding to invest in high-quality services and aged care homes that Australians expect…

As a result, Regis will now commence three greenfield developments in FY 2025, which will add 323 high quality beds to the portfolio.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Man in business suit carries box of personal effects
Healthcare Shares

Monash IVF shares jump 9% as CEO quits after second embryo incident

Two incidents at its clinics have cost this CEO his job.

Read more »

Woman with an amazed expression has her hands and arms out with a laptop in front of her.
Share Gainers

Guess which ASX 200 stock turned $5,000 into $34,264 in just three years!

Investors have been piling into this ASX 200 stock for years, sending the share price soaring.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Healthcare Shares

Cochlear shares sink 9% on guidance downgrade

Investors haven't responded positively to this update. Let's dig deeper into it.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

Telix shares push higher on investor day update

This radiopharmaceuticals company has grand plans for the future.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Healthcare Shares

3 leading ASX healthcare shares with global reach

These 3 healthcare companies are having an outsized impact far beyond local markets.

Read more »

Man looks shocked as he works on laptop on top a skyscraper with stockmarket figures in graphic behind him.
Healthcare Shares

Macquarie tips more than 100% upside for this ASX All Ords healthcare stock

This company could be set to soar.

Read more »

A little boy, soon to be a brother, kisses and holds his mum's pregnant tummy.
Healthcare Shares

Monash IVF shares fall 25% following second embryo incident

Its been a forgettable start to 2025 for Monash IVF shareholders.

Read more »

Shot of two young scientists using a laptop in a laboratory.
Healthcare Shares

Buying CSL shares? Meet your new board director

CSL’s new board director has spent the last 11 years in an executive role at Australia’s $240 billion Future Fund.

Read more »